Brind.

Goldman Sachs initiated coverage on Amneal Pharmaceuticals, noting its headquarters in Bridgewater and Gautam Patel as director.

1 report, 0 independent Updated Jul 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Goldman Sachs initiated coverage on Amneal Pharmaceuticals, noting its headquarters in Bridgewater and Gautam Patel as director.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Unknown outlet